SOURCE: Industrial Info Resources

Industrial Info Resources

April 19, 2011 06:35 ET

Pharmaceutical-Biotech Industry Kicks Off Spring With a Roar: $4.5 Billion Investment in 2Q11 Project Starts More Than Double 2Q10, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - Apr 19, 2011) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The news is filled with dire predictions regarding the economy, with each day warning of darker days ahead. Yet, a ray of light beams out from the Pharmaceutical-Biotech Industry, as the sector prepares to kick off $4.5 billion in capital and maintenance projects during the second quarter of this year. This figure is more than double what the industry delivered in second-quarter 2010 (source: Industrial Info's Pharmaceutical Tracker - Online Database).

Major projects of Novo Nordisk U.S. (NASDAQ:NVO) (Princeton, New Jersey) and Watson Pharmaceuticals Incorporated (NYSE:WPI) are planned to begin before the end of June this year.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=177607, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with world headquarters in Sugar Land, Texas, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. IIR's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Follow us on: Facebook - Twitter - LinkedIn

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147